Ebola: A significant threat as an infectious disease, and as a potential bioterrorism agent

Turkish Journal of Medical Sciences

Volumn 35, Issue 1, 2005, Pages 1-4

  Üstün, Çaǧatay ^a   Özgürler, Özge ^b  

^a EGE UNIVERSITY   (Turkey)

^b KOÇ UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; RIBAVIRIN;

AEROSOL; BACILLUS SUBTILIS; BIOLOGICAL WARFARE; BRUCELLA; CLOSTRIDIUM BOTULINUM; EBOLA VIRUS; ENVIRONMENTAL FACTOR; EPIDEMIC; FATALITY; FRANCISELLA TULARENSIS; HOSPITAL PERSONNEL; HUMAN; MONKEY; NONHUMAN; NOTE; PALLIATIVE THERAPY; PATIENT CARE; SMALLPOX; SYMPTOMATOLOGY; VIRUS CARRIER; VIRUS HEMORRHAGIC FEVER; VIRUS PARTICLE; VIRUS TRANSMISSION; YERSINIA PESTIS;

EID: 14944367781     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (11)

1. Sodhi, A. Ebola virus disease. Recognizing the face of a rare killer. Postgrad Med, 99: 75-76, 1996.
2. Bruce J, Brysiewicz P. Ebola fever: The African emergency. Int J Trauma Nurs, 8: 36-41, 2002.
3. Colebunders, R, Borchert, M. Ebola haemorrhagic fever-a review. J Infect, 40: 16-20, 2000.
4. UKCIP Climate Scenarios (2002). www.environmentagency.gov. uk/commondata/105385/w5b_029_pr_761625.pdf
5. South Dakota Department of Health. Bioterrorism (2004) www.state.sd.us/doh/Pubs/bio.htm
6. Ebola haemorrhagic fever in the Republic of the Congo - update 6, 2004. www.who.int/disease-outbreak-news/disease/A98. 4.htm
7. Murphy Talks about the Ebola Virus (n.d). www.accessexcellence. org/WN/NM/interview_murphy.html.
8. Johnson E, Jaax N, White J et al. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol, 76, 227-236, 1995.
9. Geisbert TW, Jahrling PB Towards a vaccine against Ebola virus. Expert Rev Vaccines, 2003, 2, 777-789, 2003.
10. Polesky A, Bhatia G Ebola hemorrhagic fever in the era of bioterrorism. Semin Respir Infect, 18, 206-215, 2003.
11. Bronze MS, Greenfield RA. Therapeutic options for diseases due to potential viral agents of bioterrorism. Curr Opin Investig Drugs, 4, 172-178, 2003.